CY1117682T1 - Παραγωγα δικυκλο(3.1.0)εξανο-2,6-δικαρβοξυλικου οξεος ως αγωνιστης του υποδοχεα mglu2 - Google Patents
Παραγωγα δικυκλο(3.1.0)εξανο-2,6-δικαρβοξυλικου οξεος ως αγωνιστης του υποδοχεα mglu2Info
- Publication number
- CY1117682T1 CY1117682T1 CY20161100570T CY161100570T CY1117682T1 CY 1117682 T1 CY1117682 T1 CY 1117682T1 CY 20161100570 T CY20161100570 T CY 20161100570T CY 161100570 T CY161100570 T CY 161100570T CY 1117682 T1 CY1117682 T1 CY 1117682T1
- Authority
- CY
- Cyprus
- Prior art keywords
- dicarbowlic
- agonor
- exano
- producers
- bicycle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382208 | 2011-06-17 | ||
| US201161522791P | 2011-08-12 | 2011-08-12 | |
| EP12729769.5A EP2721012B1 (en) | 2011-06-17 | 2012-06-07 | Bicyclo(3.1.0)hexane-2,6-dicarboxylic acid derivatives as mglu2 receptor agonist |
| PCT/US2012/041229 WO2012173850A1 (en) | 2011-06-17 | 2012-06-07 | Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117682T1 true CY1117682T1 (el) | 2017-05-17 |
Family
ID=47357416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100570T CY1117682T1 (el) | 2011-06-17 | 2016-06-24 | Παραγωγα δικυκλο(3.1.0)εξανο-2,6-δικαρβοξυλικου οξεος ως αγωνιστης του υποδοχεα mglu2 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9296710B2 (OSRAM) |
| EP (1) | EP2721012B1 (OSRAM) |
| JP (1) | JP5945592B2 (OSRAM) |
| KR (1) | KR101598679B1 (OSRAM) |
| CN (1) | CN103596933B (OSRAM) |
| AU (1) | AU2012271024B2 (OSRAM) |
| BR (1) | BR112013031928B1 (OSRAM) |
| CA (1) | CA2836485C (OSRAM) |
| CY (1) | CY1117682T1 (OSRAM) |
| DK (1) | DK2721012T3 (OSRAM) |
| EA (1) | EA023553B1 (OSRAM) |
| ES (1) | ES2587204T3 (OSRAM) |
| HR (1) | HRP20160676T1 (OSRAM) |
| HU (1) | HUE030171T2 (OSRAM) |
| MX (1) | MX2013014802A (OSRAM) |
| PL (1) | PL2721012T3 (OSRAM) |
| PT (1) | PT2721012T (OSRAM) |
| RS (1) | RS54888B1 (OSRAM) |
| SI (1) | SI2721012T1 (OSRAM) |
| WO (1) | WO2012173850A1 (OSRAM) |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993006127A1 (en) | 1991-09-17 | 1993-04-01 | Warner-Lambert Company | Novel amino acid prodrug renin inhibitors |
| US5576323A (en) | 1993-12-03 | 1996-11-19 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| US5849525A (en) | 1994-03-09 | 1998-12-15 | Brigham And Women's Hospital, Inc. | Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same |
| US5688826A (en) | 1995-11-16 | 1997-11-18 | Eli Lilly And Company | Excitatory amino acid derivatives |
| GB9605429D0 (en) | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
| IL124487A (en) | 1995-11-16 | 2001-01-11 | Lilly Co Eli | Excitatory amino acid derivatives, their preparation and pharmaceutical compositions containing them |
| US5952294A (en) | 1996-07-31 | 1999-09-14 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Peptidyl prodrugs and methods of making and using the same |
| ZA983930B (en) | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| CA2318800C (en) | 1998-01-28 | 2005-12-20 | Taisho Pharmaceutical Co., Ltd. | Fluorine-containing amino acid derivatives |
| PT1110943E (pt) | 1998-08-31 | 2004-08-31 | Taisho Pharmaceutical Co Ltd | Derivados 6-fluorobiciclo¬3.1.0|hexano |
| US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| CN1216038C (zh) | 2000-06-28 | 2005-08-24 | 大正制药株式会社 | 新型二羧酸衍生物 |
| US7038077B2 (en) | 2001-01-11 | 2006-05-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| US7256217B2 (en) | 2001-01-11 | 2007-08-14 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| EP1370519A1 (en) * | 2001-02-22 | 2003-12-17 | Eli Lilly And Company | Synthetic excitatory amino acids |
| CA2450167A1 (en) | 2001-06-12 | 2002-12-19 | Elan Pharmaceuticals, Inc. | Macrocycles useful in the treatment of alzheimer's disease |
| MXPA04006322A (es) | 2001-12-27 | 2004-10-04 | Taisho Pharmaceutical Co Ltd | Derivados de 6-fluorobiciclo[3.1.0]hexano. |
| US20050192273A1 (en) | 2002-04-03 | 2005-09-01 | Johnson Bryan G. | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| CA2478227A1 (en) | 2002-04-03 | 2003-10-16 | Eli Lilly And Company | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| ATE421526T1 (de) | 2002-06-11 | 2009-02-15 | Lilly Co Eli | Prodrugs von exzitatorischen aminosäuren |
| CN100482680C (zh) * | 2002-06-11 | 2009-04-29 | 伊莱利利公司 | 兴奋性氨基酸前药 |
| CN100582087C (zh) * | 2003-06-26 | 2010-01-20 | 大正制药株式会社 | 2-氨基-双环[3.1.0]己烷-2,6-二甲酸酯衍生物 |
| US7381746B2 (en) * | 2003-06-26 | 2008-06-03 | Taisho Pharmaceutical Co., Ltd. | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| EA020506B1 (ru) * | 2009-11-18 | 2014-11-28 | Сувен Лайф Сайенсиз Лимитед | БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ЛИГАНДОВ αβНИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА |
| AR079343A1 (es) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico |
-
2012
- 2012-06-07 CA CA2836485A patent/CA2836485C/en active Active
- 2012-06-07 CN CN201280029080.2A patent/CN103596933B/zh active Active
- 2012-06-07 BR BR112013031928-3A patent/BR112013031928B1/pt active IP Right Grant
- 2012-06-07 MX MX2013014802A patent/MX2013014802A/es active IP Right Grant
- 2012-06-07 PL PL12729769T patent/PL2721012T3/pl unknown
- 2012-06-07 KR KR1020137033028A patent/KR101598679B1/ko active Active
- 2012-06-07 EP EP12729769.5A patent/EP2721012B1/en active Active
- 2012-06-07 HU HUE12729769A patent/HUE030171T2/en unknown
- 2012-06-07 JP JP2014515878A patent/JP5945592B2/ja active Active
- 2012-06-07 EA EA201391700A patent/EA023553B1/ru not_active IP Right Cessation
- 2012-06-07 HR HRP20160676TT patent/HRP20160676T1/hr unknown
- 2012-06-07 AU AU2012271024A patent/AU2012271024B2/en active Active
- 2012-06-07 DK DK12729769.5T patent/DK2721012T3/en active
- 2012-06-07 RS RS20160491A patent/RS54888B1/sr unknown
- 2012-06-07 PT PT127297695T patent/PT2721012T/pt unknown
- 2012-06-07 WO PCT/US2012/041229 patent/WO2012173850A1/en not_active Ceased
- 2012-06-07 US US14/123,768 patent/US9296710B2/en active Active
- 2012-06-07 ES ES12729769.5T patent/ES2587204T3/es active Active
- 2012-06-07 SI SI201230569A patent/SI2721012T1/sl unknown
-
2016
- 2016-06-24 CY CY20161100570T patent/CY1117682T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012271024B2 (en) | 2015-07-09 |
| CA2836485A1 (en) | 2012-12-20 |
| US20140113944A1 (en) | 2014-04-24 |
| SI2721012T1 (sl) | 2016-08-31 |
| PL2721012T3 (pl) | 2017-05-31 |
| PT2721012T (pt) | 2016-07-27 |
| HRP20160676T1 (hr) | 2016-07-15 |
| WO2012173850A1 (en) | 2012-12-20 |
| CN103596933A (zh) | 2014-02-19 |
| US9296710B2 (en) | 2016-03-29 |
| BR112013031928B1 (pt) | 2022-05-24 |
| MX2013014802A (es) | 2014-01-24 |
| CA2836485C (en) | 2016-12-13 |
| JP5945592B2 (ja) | 2016-07-05 |
| HUE030171T2 (en) | 2017-05-29 |
| CN103596933B (zh) | 2016-03-23 |
| ES2587204T3 (es) | 2016-10-21 |
| AU2012271024A1 (en) | 2013-11-21 |
| RS54888B1 (sr) | 2016-10-31 |
| EP2721012B1 (en) | 2016-05-25 |
| DK2721012T3 (en) | 2016-08-15 |
| BR112013031928A2 (pt) | 2016-12-13 |
| JP2014517035A (ja) | 2014-07-17 |
| EP2721012A1 (en) | 2014-04-23 |
| EA201391700A1 (ru) | 2014-04-30 |
| KR101598679B1 (ko) | 2016-02-29 |
| KR20140009568A (ko) | 2014-01-22 |
| EA023553B1 (ru) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125421T1 (el) | Ριβονουκλεϊκα οξεα που περιεχουν ν1-μεθυλο- ψευδοουρακιλες και χρησεις αυτων | |
| CY1123079T1 (el) | Τροποποιημενα πολυπεπτιδια γiα ικριωματα διειδικων αντισωματων | |
| CY1119098T1 (el) | Αγωνιστες fgfr1 και μεθοδοι χρησης | |
| BR112013027500A2 (pt) | liberação controlada de imunossupressores de nanotransportadores sintéticos | |
| UY34352A (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante | |
| UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
| CY1119804T1 (el) | Συντηγμενες τετρα- ή πεντα-κυκλικες διϋδροδιαζεπινοκαρβαζολονες ως αναστολεις parp | |
| UY34342A (es) | ?derivados de pirrolopirimidina y purina?. | |
| JO3131B1 (ar) | مركبات كيميائية | |
| UA110880C2 (uk) | Заміщені амідином бета-лактами, їх одержання та застосування як антибактеріальних засобів | |
| UY34515A (es) | Triazolopiridinas sustituidas | |
| UY34374A (es) | Benzilindazoles sustituidos | |
| UY34037A (es) | Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias. | |
| BR112015012987A2 (pt) | composições compreendendo anticorpos anti-cd38 e lenalidomida | |
| BR112014004828A2 (pt) | método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração | |
| TN2012000281A1 (en) | Mglu2 agonists | |
| CR20130539A (es) | Triazolopiridinas | |
| UY33910A (es) | 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del SNC | |
| EA201590854A1 (ru) | Пиридин-2-амиды, пригодные в качестве агонистов каннабиноидного рецептора 2 | |
| NZ708443A (en) | Solution formulations of engineered anti-il-23p19 antibodies | |
| RU2011135537A (ru) | Штамм enterococcus hirae, используемый при производстве кисломолочных продуктов | |
| CY1116720T1 (el) | Παραγωγα 2-αμινο-3-(ιμιδαζολ-2-υλ)-πυριδιν-4-ονης και η χρηση τους ως αναστολεις κινασης υποδοχεα vegf | |
| UY34223A (es) | Formulaciones de (trimetoxifenilamino)pirimidinilo nuevas | |
| CO7160067A2 (es) | Formulaciones de agonistas del receptor de somatostatina | |
| EA201690434A1 (ru) | Маркирующие соединения и их применение в анализах |